Actos News
Most Popular Actos Story
GSK shakes up R&D
Like so many other big drug developers, GlaxoSmithKline has announced that it will be shaking up its R&D operations. The goal? To create new drugs faster and cheaper. Speaking to the Financial... Read more...
Latest Headlines
- April 10, 2008
- March 28, 2008
- December 12, 2007
- October 29, 2007
- July 30, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
